Search Results

4676 - 4700 of 76645
TitleWireDateTime
NANO Nuclear Energy and Hyundai Engineering Sign Memorandum of Understanding to Advance KRONOS MMR™ Project Execution and Future Fleet Deployment Globe Newswire 10/27 08:00
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors Globe Newswire 10/27 08:00
Schneider Electric, Nscale and Start Campus Bring the NVIDIA Omniverse DSX Blueprint into a Live AI Factory Environment Globe Newswire 10/27 08:00
Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering Globe Newswire 10/27 08:00
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union Globe Newswire 10/27 08:00
Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026 Globe Newswire 10/27 08:00
Pasqal’s Neutral-Atom Processor Uncovers Quantum Magnet Behavior That Theory Did Not Predict Globe Newswire 10/27 08:00
Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline Globe Newswire 10/27 08:00
Genius Group, FingerMotion and BlueFlare Sign Binding Agreements to Launch GENIUSpark Alberta, with First High-Performance Computing Campus at Hanna, Alberta Globe Newswire 10/27 08:00
Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development Globe Newswire 10/27 08:00
Mazda Selects CCC Intelligent Solutions to Deliver on Parts Strategy Globe Newswire 10/27 08:00
Absci to Participate in Upcoming Investor Conferences Globe Newswire 10/27 08:00
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning Globe Newswire 10/27 08:00
Skyline Bankshares, Inc. Announces Third Quarter 2026 Results Globe Newswire 10/27 08:00
BC Partners to Increase Ownership Stake in Mount Logan Capital Inc. Globe Newswire 10/27 08:00
OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly Globe Newswire 10/27 08:00
HomesToLife Announces Results of Extraordinary General Meeting Globe Newswire 10/27 08:00
Global Indemnity Group Q3 2026 Earnings Release & Conference Call Globe Newswire 10/27 08:00
WISeSat.Space and Kaynes Space Technology Advance Partnership to Develop Post-Quantum Security for Indian Satellites Globe Newswire 10/27 08:00
Auburn National Bancorporation, Inc. Reports Third Quarter Net Earnings Globe Newswire 10/27 08:00
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline - RGRD Law Globe Newswire 10/27 07:59
Post Road Management acquires majority interest in 1 E. Broad in downtown Bethlehem Globe Newswire 10/27 07:58
Meet Patel's Passion Farms Reports 20% Year-Over-Year Growth Across Multi-State Operations Globe Newswire 10/27 07:34
Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases Globe Newswire 10/27 07:30
InflaRx Announces November Investor Events Globe Newswire 10/27 07:30
4676 - 4700 of 76645

News, Photo and Web Search